Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Cerecor Inc. (NASDAQ: CERC).

Full DD Report for CERC

You must become a subscriber to view this report.


Recent News from (NASDAQ: CERC)

Cerecor CEO to Present at the H.C. Wainwright Global Investment Conference
BALTIMORE, Aug. 31, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on the near-term goal of becoming a leader in the U.S. pediatric market space, today announced that the Company’s management will present and host investor meetings at the H....
Source: GlobeNewswire
Date: August, 31 2018 07:00
Daily Insider Ratings Round Up 8/20/18
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
Source: SeekingAlpha
Date: August, 22 2018 15:46
Cerecor Reports Second Quarter 2018 Financial Results
BALTIMORE, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), an integrated biopharmaceutical company focused on pediatric healthcare and developing innovative therapies that make a difference in the lives of patients (“Cerecor” or the “Company”) toda...
Source: GlobeNewswire
Date: August, 09 2018 06:30
Your Daily Pharma Scoop: Theravance Positive, Denali Encouraging, Redhill Clarifies Data
Stocks in News: TBPH, DNLI Theravance's TD-9855 shows positive effect in low blood pressure disorder study Theravance Biopharma ( TBPH ) reported positive data of a four-week data from a Phase 2 clinical trial of TD-9855. The candidate is an once-daily norepinephrine and serotonin reup...
Source: SeekingAlpha
Date: August, 03 2018 00:56
Cerecor Announces First Patient Enrolled in Phase I Trial for Neurogenic Orthostatic Hypotension (nOH) in Parkinson's Disease
Study to evaluate safety, tolerability and effects on blood pressure of CERC-301 in patients with nOH BALTIMORE, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), today announced that it has enrolled the first patient in a Phase I study of its proprietary drug candida...
Source: GlobeNewswire
Date: August, 01 2018 06:30
Daily Insider Ratings Round Up 7/18/18
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
Source: SeekingAlpha
Date: July, 20 2018 08:52
Cerecor expands leadership team
Cerecor (NASDAQ: CERC ) announces executive management changes and appoints Joe Miller as CFO, Dr. Pericles Calias as Chief Scientific Officer and Jamie Harrell as Executive VP of Marketing and Investor Relations, effective today. More news on: Cerecor, Healthcare stocks news, Read m...
Source: SeekingAlpha
Date: July, 16 2018 06:59
Cerecor Announces Expansion of Leadership Team
New Leadership Supports Company Evolution into Innovative Specialty Pharmaceutical Company BALTIMORE, July 16, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ:CERC), today announced executive management changes that continue the Company’s strategic shift and further align its org...
Source: GlobeNewswire
Date: July, 16 2018 06:00
Aptinyx IPO: It Collaborated With Allergan, But Shares Are Not Cheap
With an impressive team of professionals, tons of cash in the balance sheet, and three product candidates, Aptinyx (APTX) looks like an opportunity. The fact that remarkable underwriters worked with the company is the first feature to like. Have a look at the image below: Source: S-1 Bus...
Source: SeekingAlpha
Date: June, 27 2018 13:00
BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced it has closed its previously announced $50 million registered direct offering of newly designated Series B Non-Voting Convertible Preferred Stock.  The offering closed...
Source: GlobeNewswire
Date: May, 22 2018 08:29

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-143.363.323.403.2754,372
2018-12-133.393.383.483.3846,404
2018-12-123.423.383.453.3646,048
2018-12-113.363.363.43193.331162,612
2018-12-103.343.353.443.3285,834

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1473325,2462.9034Cover
2018-12-131,8016,88226.1697Cover
2018-12-121,6039,95816.0976Cover
2018-12-113,55416,26021.8573Cover
2018-12-105,80224,80723.3886Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CERC.


About Cerecor Inc. (NASDAQ: CERC)

Logo for Cerecor Inc. (NASDAQ: CERC)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $116,418,976 - 05/15/2018
  • Issue and Outstanding: 31,379,778 - 03/16/2018

 


Recent Filings from (NASDAQ: CERC)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 17 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 11 2018
Prospectus filed under Rule 424(b)(3)
Filing Type: 424B3Filing Source: edgar
Filing Date: May, 11 2018
Amendment to a previously filed 8-K
Filing Type: 8-K/AFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 27 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 18 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 18 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 10 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 05 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 05 2018

 

 


Daily Technical Chart for (NASDAQ: CERC)

Daily Technical Chart for (NASDAQ: CERC)


Stay tuned for daily updates and more on (NASDAQ: CERC)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CERC)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CERC is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CERC and does not buy, sell, or trade any shares of CERC. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/